The European market has recently shown signs of recovery, with the pan-European STOXX Europe 600 Index climbing 3.93% over the past week, buoyed by the European Central Bank's interest rate cuts and a delay in tariff impositions. This positive shift in sentiment has created an opportune environment for small-cap stocks, which often thrive on improved economic conditions and investor optimism. In such a dynamic market landscape, identifying stocks with strong fundamentals and insider buying can provide valuable insights into potential growth opportunities within the small-cap sector. Top 10 Undervalued Small Caps With Insider Buying In Europe Name PE PS Discount to Fair Value Value Rating Morgan Advanced Materials 10.2x 0.5x 44.52% ★★★★★★ Vanquis Banking Group NA 0.6x 39.93% ★★★★★★ Tristel 27.2x 3.8x 28.24% ★★★★★☆ Savills 23.4x 0.5x 43.72% ★★★★☆☆ Seeing Machines NA 1.8x 48.38% ★★★★☆☆ Norcros 23.9x 0.6x 29.15% ★★★☆☆☆ FRP Advisory Group 12.4x 2.2x 10.21% ★★★☆☆☆ Italmobiliare 10.7x 1.4x -251.44% ★★★☆☆☆ Arendals Fossekompani 20.7x 1.6x 48.63% ★★★☆☆☆ Speedy Hire NA 0.2x -6.83% ★★★☆☆☆ Click here to see the full list of 63 stocks from our Undervalued European Small Caps With Insider Buying screener. We're going to check out a few of the best picks from our screener tool. NIOX Group Simply Wall St Value Rating: ★★★☆☆☆ Overview: NIOX Group focuses on developing and commercializing respiratory diagnostic products, with a market cap of approximately £0.23 billion. Operations: The company generates its revenue primarily from NIOX® products, with a recent gross profit margin of 72.25%. Operating expenses include significant allocations to sales and marketing as well as general and administrative costs. The net income margin has shown fluctuations, with the most recent figure at 8.13%. PE: 69.3x NIOX Group, a small European company, has recently seen its proposal for acquisition by Keensight Capital cancelled due to macroeconomic conditions. Despite this setback, the company recommended a final dividend of 1.25 pence per share for 2024 and reported sales growth to £41.8 million from £36.8 million the previous year, although net income decreased to £3.7 million from £10.7 million. Insider confidence is evident with recent insider buying activity noted earlier this year, reflecting potential optimism about future earnings growth projected at 43% annually despite current challenges in profit margins and volatile share prices over recent months. Click to explore a detailed breakdown of our findings in NIOX Group's valuation report. Gain insights into NIOX Group's past trends and performance with our Past report. Story Continues AIM:NIOX Share price vs Value as at Apr 2025 Warpaint London Simply Wall St Value Rating: ★★★★★★ Overview: Warpaint London is a cosmetics company specializing in the manufacture and sale of own-brand and close-out makeup products, with a market cap of £0.25 billion. Operations: The company generates revenue primarily from its Own Brand segment, which significantly outweighs the Close-Out segment. Over time, the net income margin has shown a notable upward trajectory, reaching 17.35% as of June 2024. The cost of goods sold (COGS) and operating expenses are substantial components of its financial structure, with COGS being a major expense driver. PE: 17.0x Warpaint London, a small cosmetics company, has been catching attention due to its potential for growth and insider confidence. Recent insider purchases in February 2025 suggest belief in the company's prospects. Despite a highly volatile share price over the past three months, earnings are projected to grow by 15% annually. The company anticipates revenue of £102 million for 2024, indicating a positive trajectory despite reliance on external borrowing as its sole funding source. Navigate through the intricacies of Warpaint London with our comprehensive valuation report here. Review our historical performance report to gain insights into Warpaint London's's past performance.AIM:W7L Share price vs Value as at Apr 2025 Coats Group Simply Wall St Value Rating: ★★★★★☆ Overview: Coats Group is a global leader in industrial thread manufacturing, serving sectors such as apparel, footwear, and performance materials with a market capitalization of approximately £1.22 billion. Operations: The company generates revenue primarily from Apparel ($769.80 million), Footwear ($403.50 million), and Performance Materials ($327.60 million) segments. Over the observed periods, the gross profit margin has shown a notable upward trend, reaching 36.28% by mid-2024 from 31.68% in late 2020, indicating improved cost management or pricing strategies relative to COGS. PE: 19.2x Coats Group, a European small-cap company, is navigating strategic shifts by exiting its non-core US Yarns business to enhance EBIT margins and focus on growth areas. Despite relying solely on external borrowing, the company maintains a solid financial position with earnings projected to grow 18.58% annually. Recent results show sales of US$1.5 billion and net income rising to US$80 million for 2024. Insider confidence is evident with share purchases in early 2025, signaling potential value appreciation ahead. Click here and access our complete valuation analysis report to understand the dynamics of Coats Group. Assess Coats Group's past performance with our detailed historical performance reports.LSE:COA Share price vs Value as at Apr 2025 Summing It All Up Unlock our comprehensive list of 63 Undervalued European Small Caps With Insider Buying by clicking here. Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:NIOX AIM:W7L and LSE:COA. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 Undervalued European Small Caps With Insider Buying
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...